Latest From Transgenomic Inc.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, this new bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. This month we highlight deals announced in July and August 2016.
AACR-ROUND-UP: A Novel Drug Delivery System And More Liquid Biopsy Results Highlight New Orleans Meeting
Highlights from the American Association for Cancer Research (AACR) Annual Meeting on April 19 include an implantable microdevice for evaluating drug efficacy in treating breast cancer tumors, as well as the latest research and innovation in liquid biopsy testing.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Laboratory Testing Services
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Transgenomic Inc.
- Senior Management
Paul Kinnon, Pres. & CEO & Interim CFO
Katherine A Richardson, PhD, VP, R&D
- Contact Info
Phone: (402) 452-5400
12325 Emmet St.
Omaha, NE 68164
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.